Works by Muneaki Shimada


Results: 107
    1
    2

    Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 3, p. 247, doi. 10.1007/s00280-003-0714-9
    By:
    • Sato, Shinya;
    • Kigawa, Junzo;
    • Kanamori, Yasunobu;
    • Itamochi, Hiroaki;
    • Oishi, Tetsuro;
    • Shimada, Muneaki;
    • Iba, Takahiro;
    • Naniwa, Jun;
    • Uegaki, Kazunori;
    • Terakawa, Naoki
    Publication type:
    Article
    3
    4
    5
    6
    7

    Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1242, doi. 10.1093/jjco/hyac127
    By:
    • Kukimoto, Iwao;
    • Onuki, Mamiko;
    • Yamamoto, Kasumi;
    • Yahata, Hideaki;
    • Aoki, Yoichi;
    • Yokota, Harushige;
    • Konnai, Katsuyuki;
    • Nio, Ai;
    • Takehara, Kazuhiro;
    • Kamiura, Shoji;
    • Tsuda, Naotake;
    • Takei, Yuji;
    • Shimada, Muneaki;
    • Nakai, Hidekatsu;
    • Yoshida, Hiroyuki;
    • Motohara, Takeshi;
    • Yamazaki, Hiroyuki;
    • Nakamura, Keiichiro;
    • Okunomiya, Asuka;
    • Tasaka, Nobutaka
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

    Published in:
    Cancers, 2024, v. 16, n. 22, p. 3801, doi. 10.3390/cancers16223801
    By:
    • Shoji, Tadahiro;
    • Takatori, Eriko;
    • Nagasawa, Takayuki;
    • Kagabu, Masahiro;
    • Baba, Tsukasa;
    • Shigeto, Tatsuhiko;
    • Matsumura, Yukiko;
    • Shimizu, Dai;
    • Terada, Yukihiro;
    • Seino, Manabu;
    • Ohta, Tsuyoshi;
    • Nagase, Satoru;
    • Shigeta, Shogo;
    • Tokunaga, Hideki;
    • Shimada, Muneaki;
    • Kaiho-Sakuma, Michiko;
    • Furukawa, Shigenori;
    • Soeda, Shu;
    • Watanabe, Takafumi;
    • Takahashi, Fumiaki
    Publication type:
    Article
    14

    Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group).

    Published in:
    Cancers, 2023, v. 15, n. 6, p. 1730, doi. 10.3390/cancers15061730
    By:
    • Seki, Toshiyuki;
    • Kojima, Atsumi;
    • Okame, Shinichi;
    • Yamaguchi, Satoshi;
    • Okamoto, Aikou;
    • Tokunaga, Hideki;
    • Nishio, Shin;
    • Takei, Yuji;
    • Yokoyama, Yoshihito;
    • Yoshida, Manabu;
    • Teramoto, Norihiro;
    • Mikami, Yoshiki;
    • Shimada, Muneaki;
    • Kigawa, Junzo;
    • Takehara, Kazuhiro
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 10, p. 1594, doi. 10.1007/s10147-024-02585-1
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Takehara, Kazuhiro;
    • Sato, Shinya;
    • Satoh, Toyomi;
    • Shimada, Muneaki;
    • Yamaguchi, Satoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Horie, Kouji;
    • Takei, Yuji;
    • Imai, Yuichi;
    • Hibino, Yumi;
    • Hasegawa, Kosei;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Takano, Hirokuni;
    • Fujiwara, Keiichi;
    • Masuyama, Hisashi
    Publication type:
    Article
    31

    Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 9, p. 1334, doi. 10.1007/s10147-024-02552-w
    By:
    • Kawabata-Iwakawa, Reika;
    • Iwasa, Norihiro;
    • Satoh, Kenichi;
    • Colinge, Jacques;
    • Shimada, Muneaki;
    • Takeuchi, Satoshi;
    • Fujiwara, Hiroyuki;
    • Eguchi, Hidetaka;
    • Oishi, Tetsuro;
    • Sugiyama, Toru;
    • Suzuki, Mitsuaki;
    • Hasegawa, Kosei;
    • Fujiwara, Keiichi;
    • Nishiyama, Masahiko
    Publication type:
    Article
    32

    Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1874, doi. 10.1007/s10147-022-02246-1
    By:
    • Shoji, Tadahiro;
    • Takatori, Eriko;
    • Nagasawa, Takayuki;
    • Kagabu, Masahiro;
    • Baba, Tsukasa;
    • Shigeto, Tatsuhiko;
    • Matsumura, Yukiko;
    • Shimizu, Dai;
    • Terada, Yukihiro;
    • Seino, Manabu;
    • Ohta, Tsuyoshi;
    • Nagase, Satoru;
    • Shigeta, Shogo;
    • Tokunaga, Hideki;
    • Shimada, Muneaki;
    • Kaiho-Sakuma, Michiko;
    • Furukawa, Shigenori;
    • Soeda, Shu;
    • Watanabe, Takafumi;
    • Takahashi, Fumiaki
    Publication type:
    Article
    33
    34

    Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1507, doi. 10.1007/s10147-022-02198-6
    By:
    • Shigeta, Shogo;
    • Shimada, Muneaki;
    • Tsuji, Keita;
    • Nagai, Tomoyuki;
    • Tanase, Yasuhito;
    • Matsuo, Koji;
    • Kamiura, Shoji;
    • Iwata, Takashi;
    • Yokota, Harushige;
    • Mikami, Mikio
    Publication type:
    Article
    35
    36
    37

    Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 971, doi. 10.1007/s10147-021-01862-7
    By:
    • Togami, Shinichi;
    • Kobayashi, Hiroaki;
    • Niikura, Hitoshi;
    • Shimada, Muneaki;
    • Susumu, Nobuyuki;
    • Tanaka, Tomohito;
    • Terai, Yoshito;
    • Nagai, Tomoyuki;
    • Baba, Tsukasa;
    • Yahata, Hideaki;
    • Yamagami, Wataru;
    • Yamaguchi, Ken;
    • Yamashita, Tsuyoshi;
    • Yaegashi, Nobuo;
    • Katabuchi, Hidetaka;
    • Aoki, Daisuke
    Publication type:
    Article
    38
    39

    A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1284, doi. 10.1007/s10147-019-01471-5
    By:
    • Fujiwara, Hiroyuki;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takei, Yuji;
    • Shimada, Muneaki;
    • Takano, Masashi;
    • Yoshino, Kiyoshi;
    • Kawano, Yoshiaki;
    • Hirashima, Yasuyuki;
    • Nagase, Satoru;
    • Nishio, Shin;
    • Nishikawa, Tadaaki;
    • Ito, Kimihiko;
    • Shoji, Tadahiro;
    • Kimura, Eizo;
    • Takano, Tadao;
    • Sugiyama, Toru;
    • Kigawa, Junzo;
    • Fujiwara, Keiichi;
    • Suzuki, Mitsuaki
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer.

    Published in:
    Toxins, 2021, v. 13, n. 7, p. 461, doi. 10.3390/toxins13070461
    By:
    • Hishinuma, Eiji;
    • Shimada, Muneaki;
    • Matsukawa, Naomi;
    • Saigusa, Daisuke;
    • Li, Bin;
    • Kudo, Kei;
    • Tsuji, Keita;
    • Shigeta, Shogo;
    • Tokunaga, Hideki;
    • Kumada, Kazuki;
    • Komine, Keigo;
    • Shirota, Hidekazu;
    • Aoki, Yuichi;
    • Motoike, Ikuko N.;
    • Yasuda, Jun;
    • Kinoshita, Kengo;
    • Yamamoto, Masayuki;
    • Koshiba, Seizo;
    • Yaegashi, Nobuo
    Publication type:
    Article
    48
    49
    50